Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: AJR Am J Roentgenol. 2020 Oct 14;217(3):720–729. doi: 10.2214/AJR.20.24509

Fig. 2—

Fig. 2—

77-year-old man with biopsy-proven Gleason score 4 + 5 prostate cancer in left base and serum PSA level of 8.4 ng/mL with negative conventional staging (no evidence of metastatic disease).

A–C, DWI (b value, 2000 s/mm2) (A), apparent diffusion coefficient map (B), and small FOV T2-weighted MRI (C) images show large PI-RADS 5 lesion in left base with T2-weighted hypointensity and marked restricted diffusion (thin arrow). Open arrow shows uptake in transition zone.

D, Fused 18F-fluciclovine PET/MRI shows high focal activity within lesion (thin arrow). Second focus of uptake (open arrow) in transition zone with no anatomic lesion on T2-weighted images and mild corresponding restricted diffusion corresponds to benign prostatic hyperplasia nodule.